Since its founding in 2022 by pan-European private equity investor Apheon and Dr. Reinhard Wichels, Munich-based startup Ortivity has developed into Germany’s leading platform for outpatient orthopedic care. With more than 100 locations across three regional clusters, the company covers the full spectrum of orthopedic services – from diagnostics through surgery to aftercare. The foundation is a doctor-led partnership model in which ownership stakes are distributed equally between physicians and capital providers.
To implement its growth plans, Apheon strategically brought another investor on board: Unigestion, a company specializing in mid-market private equity, is investing approximately 200 million euros in Ortivity and thereby acquiring a minority stake. Apheon remains the lead investor and continues to hold the majority.
Expansion of regional clusters
The fresh capital is to be used to strengthen existing clusters and establish new ones in order to “gradually transition the German orthopedic market to a modern, outpatient model.” Nils Lüssem, partner at Apheon, and Sebastian Walter, director at Apheon, comment on this:
“The partnership with Unigestion ensures that we have the necessary capital to continue our growth and continue to invest in top-quality patient care.”
Doctor-led leadership
Ortivity sees the new partnership as a confirmation of its doctor-led model. Dr. Michael Thorwarth, newly appointed co-CEO of Ortivity, summarizes:
“Together, we want to set new standards in treatment quality and patient-centered services and create measurable benefits for our patients.”
The transaction is still subject to customary regulatory approvals.
